Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 9Brain Neoplasms 3Recurrence 2Neoplasm Metastasis 2Head and Neck Neoplasms 2Glioblastoma 2Carcinoma, Squamous Cell 2Squamous Cell Carcinoma of Head and Neck 1Skin Squamous Cell Cancer 1Rare Tumor 1Penile Neoplasms 1Non-small Cell Lung Cancer Metastatic 1Neoplasms 1NSCLC 1Lung Neoplasms 1Carcinoma 1Advanced Gastric Cancer 1

Interventions

dacomitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Skin Squamous Cell Cancer × dacomitinib × Clear all
NCT02268747 2016-07-04

Efficacy and Safety of Dacomitinib in the Treatment of Skin Squamous Cell Cancer

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown
43 enrolled

Skin Squamous Cell Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡